Medical devices are among the most closely regulated categories in China cross-border e-commerce. Whether it is a home-use monitoring instrument, a wound-care product, or a diagnostic device that requires professional operation, any product whose intended use touches disease diagnosis, prevention, monitoring, treatment, or the support and correction of body structure falls inside the medical-device regulatory framework. This article maps a complete path from classification and registration through the technical file to post-market obligations, so a brand can land compliantly under either the 1210 bonded model or general import.
Which products take the medical-device pathway
In China, a product is treated as a medical device when it is intended for diagnosis, prevention, monitoring, treatment, or alleviation of disease, or for the structural support or modification of the body. This covers a wide range: thermometers, blood-pressure monitors, pulse oximeters, glucose meters, contact lenses, wound dressings, surgical masks, rehabilitation aids, pregnancy and ovulation tests, and many home-use wellness instruments. The intended use, not the sales channel, decides the classification. Cross-border e-commerce does not relax the obligation; a device sold through a 1210 bonded store still needs the same market authorization as one shipped from an overseas warehouse. A common misconception is that a “wellness gadget” escapes control, but any claim of a medical function can pull the product into the device category.
NMPA registration and filing by risk class
China sorts medical devices into three classes by risk. Class I (low risk) is filed with the provincial regulator; Class II and Class III (moderate to high risk) require NMPA registration and a registration certificate. Foreign manufacturers cannot register directly – they must appoint a China registration agent and, for many categories, a Marketing Authorization Holder that is a legal entity in China. The dossier includes product technical requirements, risk-analysis documents, and proof of the quality system. Processing times and required testing differ sharply by class, so confirming the class early prevents months of rework. We recommend starting the class determination during design freeze rather than after mass production.
Technical documentation and clinical evaluation
The technical file is the backbone of the submission. It contains the product specification, manufacturing process, sterilization or cleaning method, labeling artwork, and test reports from a CNAS- or ILAC-accredited laboratory. Higher-risk devices need a clinical evaluation: either a literature-based comparison to an equivalent device or local clinical trial data. For many imported devices, an overseas clinical report can support the file if the study design is accepted, but the responsible team should expect requests for supplemental evidence. A clean, complete technical file is the single biggest factor in a smooth review. The labeling artwork should be supplied both as a print-ready version and as a Chinese translation to avoid late-stage rework.
Chinese labeling, instructions, and UDI
Every medical device placed on the Chinese market must carry a Chinese label and a Chinese instructions-for-use booklet. The label shows the registration certificate number, the manufacturer, the China agent, the production lot, and the expiration date; the instructions explain intended use, contraindications, and warnings in plain Chinese. From the required stage, devices must also carry a Unique Device Identification code that supports traceability through import, storage, and dispensing. Skipping the Chinese instructions is one of the most common reasons a shipment is held at customs or rejected by a platform. The instructions may not rely on illustrations alone; critical safety information must appear in clear Chinese text.
1210 bonded e-commerce and cold-chain handling
The 1210 bonded model is attractive for cross-border devices because stock sits in a China bonded zone and is cleared per order, reducing upfront duty and letting a brand test demand before a full import. Not every device fits: items needing a Chinese registration first still need that certificate, and certain high-risk or prescription devices are restricted. Temperature-sensitive devices such as reagents or certain diagnostics must follow Good Supply Practice cold-chain rules during bonded storage and last-mile delivery, with monitored logging from warehouse to door. The bonded model changes the clearance rhythm but does not remove the registration obligation.
Post-market duties: adverse events, recalls, and service
Compliance does not end at the border. The holder must run an adverse-event monitoring system, report serious incidents to NMPA within the required window, and keep a corrective-and-preventive-action record. If a defect or safety issue appears, a device recall follows a defined grading and public-notification path. After-sales service – repair, calibration, and user training – must be reachable for Chinese consumers, and the China agent is the named point of contact. Brands that plan these obligations before launch avoid the costly scramble that follows a first regulatory inquiry. A dedicated contact window and a rehearsed reporting flow are strongly advised.
A practical starting path
Start with a clear intended-use statement and a class determination, then map the required certificates and the responsible China entity. Prepare the technical file with accredited test data, translate and lay out the Chinese label and instructions, and confirm the 1210 or general-import route fits the device. Build the post-market monitoring and recall plan before the first unit ships. Treating medical-device compliance as a phased program – not a last-minute checklist – keeps a cross-border launch both legal and durable. For most brands, starting six to nine months ahead is the safest cadence.